ECFVX | VIVIX | ECFVX / VIVIX | |
Total Expense Ratio | 1.74 | 0.04 | 4,350% |
Annual Report Gross Expense Ratio | 1.81 | 0.04 | 4,525% |
Fund Existence | 15 years | 27 years | - |
Gain YTD | 3.564 | 7.866 | 45% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 236M | 203B | 0% |
Annual Yield % from dividends | 0.45 | 2.11 | 21% |
Returns for 1 year | 0.19 | 7.74 | 2% |
Returns for 3 years | 14.28 | 36.61 | 39% |
Returns for 5 years | 33.34 | 70.16 | 48% |
Returns for 10 years | 55.74 | 131.61 | 42% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSATX | 35.63 | 0.16 | +0.45% |
Goldman Sachs Small Cp Val Insghts A | |||
LGCVX | 19.68 | 0.04 | +0.20% |
Lord Abbett Global Equity R5 | |||
STRNX | 58.56 | 0.06 | +0.10% |
Sterling Capital MdCp Relatv Val C | |||
BIALX | 30.06 | -0.06 | -0.20% |
Brown Advisory Global Leaders Investor | |||
RRCOX | 63.22 | -0.21 | -0.33% |
T. Rowe Price U.S. Equity Research R |